- Medical Technology Blockchain to Dominate Big Data
- Reg A+ Paving the Way for Microcap Capital Raising
- Blockchain Transforming Healthcare Ecosystem
Sugar land, TX September, 2018-Quantum Medical Transport, Inc. (DRWN: OTC.PK)
Quantum Medical Transport, Inc. to Receive $2 Million Reg A Funding
Quantum Medical Transport, Inc. (DRWN: OTC.PK) is announcing a strategic partnership with New York City based private investment fund, Tri-Bridge Ventures, LLC. Tri-Bridge Ventures may purchase common stock equal to a value of up to Two Million Dollars ($5,000,000) when DRWN has qualified the necessary number of shares under Regulation A+ through its filed offering statement (Form 1-A). View our Reg A filing here:
These agreements establish a direct relationship with an institutional investor and long-term partner to fund the growth of the company. “The Regulation A+ is available, at our discretion providing us with both immediate and the precise amount of capital potentially needed in the future. Regulation A+, as mandated by the JOBS Act and introduced on March 25, 2015, gives non-SEC reporting companies the ability to raise up to $50,000,000 in a 12-month period. We are very close to releasing our Proof of Concept (POC) via Oracle Autonomous Blockchain Cloud (OABCS) Platform. We thank our stakeholders for your support and belief in our vision.
About Quantum Medical Transport
QUANTUM MEDICAL TRANSPORT, INC. is a medical technology data services company. The company is developing a proprietary medical blockchain technology for secure data storage and data transfer in a HIPAA compliant manner.
About Tri-Bridge Ventures, LLC
Tri-Bridge Ventures, LLC is a New York based Institutional Investor that focuses on transactions with publicly traded companies. The firm sources, structures and executes on investments in publicly traded companies with market capitalization primarily under $250 million. The Tri-Bridge Ventures team has the experience and understanding of the public markets to identify investment opportunities as well as the ability to structure bespoke equity and debt transactions.
CAUTIONARY STATEMENTS REGARDING FORWARD-LOOKING STATEMENTS
This press release contains forward-looking statements that involve a number of risks and uncertainties. Forward-looking statements generally can be identified by the use of forward-looking terminology such as “believes,” “expects,” “may,” “will,” “intends, “plans,” “should,” “seeks,” “pro forma,” “anticipates,” “estimates,” “continues,” or other variations thereof (including their use in the negative), or by discussions of strategies, plans or intentions. A number of factors could cause results to differ materially from those anticipated by such forward-looking statements, including those discussed under “Risk Factors” and “Our Business.” Forward-looking statements are subject to known and unknown risks and uncertainties and are based on potentially inaccurate assumptions that could cause actual results to differ materially from those expected or implied by the forward-looking statements. Our actual results could differ materially from those anticipated in the forward-looking statements for many reasons.